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Introduction: Impairments in the multifaceted neuropsychological construct of cognitive
impulsivity are a main feature of chronic tobacco smokers. According to the literature,
these cognitive impairments are relevant for the initiation andmaintenance of the smoking
behavior. However, the neuroanatomical correlates of cognitive impulsivity in chronic
smokers remain under-investigated.
Methods: A sample of 28 chronic smokers (mean age = 28 years) not affected
by polysubstance dependence and 24 matched non-smoker controls was recruited.
Voxel Based Morphometry (VBM) was employed to assess Gray Matter (GM) volume
differences between smokers and non-smokers. The relationships between GM volume
and behavioral manifestations of impulsive choices (5 trial adjusting delay discounting
task, ADT-5) and risky decision making (Cambridge Gambling Task, CGT) were
also investigated.
Results: VBM results revealed GM volume reductions in cortical and striatal brain
regions of chronic smokers compared to non-smokers. Additionally, smokers showed
heightened impulsive choices (p< 0.01, Cohen’s f = 0.50) and a riskier decision- making
process (p < 0.01, Cohen’s f = 0.40) compared to non-smokers. GM volume reductions
in the left Anterior Cingulate Cortex (ACC) correlated with impaired impulsive and risky
choices, while GM volume reductions in the left Ventrolateral Prefrontal Cortex (VLPFC)
and Caudate correlated with heightened impulsive choices. Reduced GM volume in the
left VLPFC correlated with younger age at smoking initiation (mean = 16 years).
Conclusion: Smokers displayed significant GM volume reductions and related cognitive
impulsivity impairments compared to non-smoker individuals. Longitudinal studies
would be required to assess whether these impairments underline neurocognitive
endophenotypes or if they are a consequence of tobacco exposure on the
adolescent brain.
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INTRODUCTION
Tobacco smoking is the leading cause of preventable death
worldwide (1). According to the World Health Organization
(WHO) (1), ∼7 million people die each year because of direct
tobacco smoking, while 1.2 million individuals die because of
second-hand smoke. Despite recent trends showing a decrease in
tobacco smoking in several developed countries, the percentage
of tobacco smokers worldwide remains dramatically high (1).
In fact, it is estimated that there are ∼1.3 billion current
tobacco smokers, 80% of these living in low and middle-income
countries (1).
Notably, impairments in the neuropsychological domain of
“cognitive impulsivity” constitute one of the main features
of substance users (2–5), including chronic tobacco smokers
(6–8). Particularly, impairments in cognitive impulsivity are
considered relevant for the initiation and chronicity of substance
use (5). Cognitive impulsivity is characterized by the cognitive
subdomains of choice impulsivity (delay discounting) and risky
decision making (2, 4). Choice impulsivity refers to the tendency
to opt for immediate pleasures/rewards (e.g., drug of abuse)
over long- term gains (e.g., long-term health) (4), while “risky
decision making” refers to a type of decisional process occurring
when a an individual engages in decisions despite the risk of
suffering known adverse consequences. Both cognitive impaired
processes are strongly predictive of treatment outcomes for
substance use and dependence, including tobacco smoking
cessation treatments (8, 9). In fact, tobacco smokers displaying
heightened impulsive choices (high delay discounting rates) are
likely to relapse and to jeopardize cessation attempts (10, 11).
Advancements in neuroimaging techniques and lesion studies
have helped to determine the neurobiological correlates of
the multifaceted nature of cognitive impulsivity in healthy
individuals by associating functional and structural disruptions
in (a) the Ventrolateral PreFrontal Cortex (VLPFC), Dorsolateral
PreFrontal Cortex (DLPFC), and lateral OrbitoFrontal Cortex
(lOFC) to heightened impulsive choices, and (b) deficits in
the Anterior Cingulate Cortex (ACC), Ventromedial PreFrontal
Cortex (VMPFC), and medial/rostral OrbitoFrontal Cortex
(mOFC) to impaired risky decision making (12). Additionally,
disruptions in the ventral and dorsal striatum (caudate and
putamen) have been related to both impaired impulsive and
risky choices (12). According to the competing neurobehavioral
decision systems theory of addiction (13) (CNDS), an imbalance
between the reward system (comprising the striatum, midbrain,
amygdala, and insula) and the executive decision system
(comprising medial and lateral prefrontal brain regions)
may explain the cognitive impulsivity impairments commonly
manifested by substance users. Specifically, a hyperactive
impulsive system and a hypoactive executive decision system
may cause a reward bias and a lack of self-control toward the
substance of abuse.
Notably, studies conducted on polysubstance users who were
tobacco smokers in addition to being dependent to other
substances such as cocaine (14), alcohol (15), and opioids
(16), all revealed an association between Gray Matter (GM)
volume reductions in fronto- cortical and striatal brain regions
and behavioral manifestations of cognitive impulsivity. Despite
studies conducted in the last decade revealing GM volume
reductions in fronto-cortical and striatal brain regions of chronic
tobacco smokers not affected by polysubstance dependence (17–
19), the relationship between these GM volume reductions and
impairments in cognitive impulsivity in chronic smokers remains
under-investigated and limited to self-reported measures of
impulsivity (20). To our knowledge, only one study conducted
by Durazzo et al. (21) investigated the relationship between GM
thickness and behavioral manifestations of cognitive impulsivity
through a decision making task (Iowa gambling task, IGT) in
41 chronic smokers with a mean age of 46 years (21). Results
of this study revealed an association between poorer decision
making and reduced cortical thickness in the ACC and VMPFC
of chronic smokers. However, no association between structural
brain deficits in frontal brain regions and impulsive choices
(delay discounting) was investigated, nor between reduced
cortical thickness and decision making under risk outside a
learning context (as assessed by the Cambridge Gambling Task,
CGT) (22).
Therefore, the aim of the current study was to test the
following hypotheses:
1) Chronic tobacco smokers not affected by polysubstance
dependence, neurodegenerative conditions and/or
psychiatric illnesses display GM volume reductions
compared to non-smoker controls in a priori brain regions
of interest such as VLPFC, lOFC, DLPFC, VMPFC,
mOFC, ACC, insula, dorsal (caudate and putamen) and
ventral striatum (globus pallidus, thalamus) in contrast
to non-smokers healthy controls. A priori regions of
interest were determined based on previous meta-analyses
investigating GM volume reductions in chronic smokers
compared to non-smokers, and on previous studies/reviews
investigating the neuroanatomical (GM) correlates of
cognitive impulsivity in substance users (studies are listed in
Supplementary Tables 1a, 1b).
2) Chronic tobacco smokers display impairments in impulsive
choices and risky decision-making compared to non-
smokers as assessed by computerized measures of
cognitive impulsivity such as the five- trial Adjusting
Delay Discounting Task (ADT-5) (23) and the Cambridge
Gambling Task (CGT) (22).
3) GM volume reductions in a priori regions of interest are
correlated to heightened impulsive choices and impaired
risky decision making in chronic smokers.
MATERIALS AND METHODS
Recruitment
Community based chronic tobacco smokers and non-smokers
were recruited through a convenient-sampling approach across
the South Eastern regions of Scotland between October 2019 and
March 2020. Different methods of recruitment were employed,
these included: Internet advertisements posted on Gumtree
and Craiglist websites, flyers distributed at local businesses
(e.g., supermarkets, leisure centers), advertisements published
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on “The Courier” regional newspaper, and word of mouth. All
participants provided written informed consent prior to the
beginning of the study. They were rewarded a total of £100 for
their full participation. The recruitment flow chart is depicted in
Supplementary Figure 1.
Enrolled participants needed to attend two experimental
sessions. These sessions were conducted on separate days
within the same week (no more than 3 days apart): The
first experimental session involved screening procedures and
computerized measures of cognitive impulsivity (impulsive
choices and risky decision making). This experimental session
was conducted at the University of St Andrews School of
Medicine in St Andrews. The second session involved a Magnetic
Resonance Imaging (MRI) procedure at the Clinical Research
Center (CRC), Ninewells Hospital, Dundee.
Inclusion and Exclusion Criteria
Participants were screened for eligibility (see
Supplementary Table 2) through objective and subjective
measurements. Specifically, an exhaled Carbon Monoxide (CO)
test was utilized to measure CO levels in participants’ breath,
while a saliva drug testing kit was employed to determine
presence (or not) for cotinine. The presence of cannabis, cocaine,
morphine, methadone, amphetamine, methamphetamine,
and benzodiazepines was assessed through a urine drug
screening test.
Chronic tobacco smokers who reported a recreational use of
cannabis (no more than twice per week) mixed with tobacco in
the same “spliff” or “joint,” and did not present symptoms of
acute intoxication (e.g., conjunctival injection, slurred speech,
agitation) at the screening session, were not excluded from the
study. In fact, the effect of recreational cannabis use on cortical
brain structures is limited (24), whereas the effect of cannabis use
on subcortical structures may be better explained by concomitant
tobacco smoking (25). Meta-analytic findings also revealed a
small effect of cannabis use on cognitive impulsivity with an
effect size of 0.30 (26). The Mini International Neuropsychiatric
Instrument (MINI) version 7.0.2 (27) was utilized to exclude the
presence of DSMV psychiatric disorders (Axis I) for participants.
A screening interview was utilized to exclude the presence of
chronic conditions (e.g., HIV, diabetes), pregnancy, neurological
disorders, and severe head injuries. Participants’ patterns of
tobacco use, smoking variables (pack years, cigarettes smoked
per day, age at regular smoking onset), and weekly use of
cannabis and alcohol were assessed through a paper and pencil
questionnaire, while severity of nicotine dependence was assessed
by using the Fagerström Test for Nicotine Dependence (FTND)




During this experimental session participants needed to complete
two computerized measures of cognitive impulsivity: The 5
trial Adjusting Delay Discounting Task (ADT-5) (23) and the
Cambridge Gambling Task (CGT) (22).
The ADT-5 measures choice impulsivity. Participants were
presented with choices between two fixed hypothetical monetary
rewards (£5 available immediately and £10 available at some time
in the future) over five trials. The delay period was adjusted
after each trial based on participants’ previous choice. Outcome
measures for this task consisted in Effective Delay 50% (ED50)
values. ED50 represents “the delay that is effective in discounting
the subjective value of the delayed reinforcer by 50%” 30. It
consists in the inverse of the discounting rate k (ED50 =
1/k) (30).
The Cambridge Gambling Task (CGT) is a computerized
measure of risky decision making outside a learning context
(22) that is part of the Cambridge Neuropsychological Test
Automated Battery (https://www.cambridgecognition.com/
cantab/cognitive-tests/executive-function/cambridge-gambling-
task-cgt/). During this task, a yellow token was hidden either in
red or blue boxes over five stages. Participants needed to guess
the location of the token by selecting a proportion of points to
bet on their decision. Each participant started with 100 points.
Participants lost or gained points depending on their choices.
Specifically, participants gained points for each correct guess
and lost points for each incorrect guess. The amount of points
gained or lost consisted in the amount of points betted by the
participants. Outcome domain measures for this task consisted
in the multiple facets of the risky decision-making process
commonly manifested by substance users (6, 16, 31). Specifically,
outcome measures consisted in (a) the average number of points
betted after choosing the most likely outcome (risk taking
score); (b) the overall proportion of points betted during the
task (overall proportion bet score) [both (a) and (b) outcome
measures reflect a propensity toward risk]; (c) the proportion
of all trials where the subject chose the majority box color,
which reflects the rationality of the participants’ decision making
process (quality of decision making score); and (d) the ability to
modify choices in light of information about the probability of
different outcomes (risk adjustment score) (6, 16, 31).
Neuroimaging
Structural T1 weighted images were acquired through a Siemens
3T Prisma-FIT scanner (Siemens Healthineers, Erlangen,
Germany). Specifically, an MP-RAGE (magnetization-prepared
rapid acquisition gradient echo) sequence was utilized to
acquire images with a voxel size 0.8 × 0.8 × 1.0 mm3 with
whole brain coverage, repetition time (TR) = 1.9 s, echo time
(TE) = 2.64ms. Flip angle = 9◦, FOV = 200mm, matrix
= 256 × 256, 176 slices, slice thickness 1mm. Scans were
reported by a consultant radiologist to rule out the presence of
incidental findings.
Statistical Analysis
Data obtained from computerized measures of cognitive
impulsivity (ADT-5, CGT) were analyzed through analyses
of covariance (ANCOVAs) to test the null hypothesis
of no differences between chronic tobacco smokers and
non-smokers in relation to impulsive choices and risky
decision-making outcome measures while controlling for
relevant sociodemographic variables such as sex, age, premorbid
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IQ, educational level, social deprivation (SIMD), and other
substances used (cannabis, alcohol). To be analyzed through
ANCOVAs, data needed to meet the assumptions of normality,
homoscedasticity, homogeneity of variances, and of homogeneity
of regression slopes. Data failing assumption of normality
and/or homogeneity of variances were Log10 transformed.
The non-parametric Kruskall-Wallis H test was employed
if data still violated assumptions of normality and/or of
homogeneity of variances after transformation. Bonferroni-
corrected pairwise comparisons with a significance level
set at p < 0.05 were utilized to control for Type-1 error.
SPSS v. 26 (SPSS Inc., USA) was utilized for this part of the
analysis. Effect sizes (Choen’s f ) were computed through the
software G∗Power.
Neuroimaging data were analyzed by applying a whole-brain
voxel-based morphometry (VBM) technique through SPM12
(https://www.fil.ion.ucl.ac.uk/spm/). T1 weighted images were
segmented into gray and white matter probability maps, these
were subsequently normalized to the Montreal Neurological
Institute (MNI) template. Modulation was performed with
Jacobian determinants to preserve the total amount of GM and
WM in each probability map. Following segmentation and spatial
normalization, images were smoothed with an 8mm Gaussian
kernel (32). Total intracranial volume was estimated by the
Computational Anatomy Toolbox (http://www.neuro.uni-jena.
de/cat/).
A two sample T-tests was utilized to assess for GM volume
differences between chronic tobacco smokers and non-
smokers across the whole brain, including a priori regions
of interest (Supplementary Tables 1a, 1b). Whole-brain
voxel-wise linear regression models were also computed to
investigate the relationship between GM volume reductions
and cognitive impulsivity outcome measures (ADT-5, CGT)
in chronic tobacco smokers. Proof of concept analyses were
conducted by computing whole-brain voxel-wise linear
regression models investigating the relationship between
GM volume reductions and tobacco exposure variables
(cigarettes smoked per day, pack years, FTND, age at regular
smoking onset).
Brain regions (including a priori regions of interest) were
identified by converting MNI coordinates into Talairach
coordinates (https://bioimagesuiteweb.github.io/webapp/
mni2tal.html), and by inserting them into the Talairach
Daemon Atlas (http://www.talairach.org/daemon.html) (16).
A cluster forming significance threshold of p < 0.05 with
a minimum of 100 contiguous voxels (k) per cluster was
employed for two sample T-tests and for voxel-wise regression
models testing the associations between GM volume and
cognitive impulsivity measures. This threshold was obtained
by applying Monte Carlo simulations (16, 33). For proof
of concept analyses a more stringent threshold of p <
0.01 with a minimum of 100 contiguous voxels per cluster
was employed. Covariates of no interest consisted in total
intracranial volume (TIV), age, and biological sex for two sample
T-tests and linear regression models. Results of whole-brain





Chronic tobacco smokers and non-smokers were well-matched
for age, Scottish index of multiple deprivation (SIMD) scores,
and units of alcohol consumed per day at the time of the first
experimental session as assessed by independent samples t-tests
(p > 0.05). Chi-square test results did also reveal the absence
of a statistically significant association between sex and smoking
status, χ2
(1)
= 0.55, p = 0.46. However, chronic tobacco smokers
displayed lower pre- morbid IQ and a lower educational level
compared to non-smokers (p < 0.05). Sociodemographic and
tobacco smoking characteristics of participants are displayed
in Table 1. At the time of the second experimental session
(MRI), chronic smoker participants were still matched for sex,
age, SIMD, and units of alcohol consumed per day to non-
smoker controls (Table 1). No significant changes in smoking
characteristics were detected between the two sessions (paired
samples t-test p > 0.05).
Cognitive Tests
5-Trial Adjusting Delay Discounting Task
A statistically significant difference was detected between chronic
tobacco smokers and non-smokers in relation to ED50 values
[F(1,44) = 11.39, p < 0.01, partial η
2
= 0.200,Cohen’s f = 0.50]
after adjusting for age, premorbid IQ, level of education, sex,
units of alcohol consumed per day, occasional cannabis use,
and SIMD covariates. Pairwise comparisons with Bonferroni
adjustment revealed that non-smokers had significantly higher
ED50 values (M= 1.89, SE= 0.21) compared to chronic smokers
(M = 0.82, SE = 0.19) with a mean difference of 1.07 (95%
CI, 0.43–1.71) p < 0.01. These results indicated that the delay
at which £10 had lost 50% of its value (ED50) was longer for
non-smokers compared to chronic smokers.
Cambridge Gambling Task
A statistically significant difference was also detected between
chronic smokers and non-smokers in relation to “risk taking”
scores [F(1,44) = 6.61, p < 0.01, partial η
2
= 0.133, Cohen’s f
= 0.39] and “overall proportion bet” scores [F(1,44) = 7.28, p
< 0.01, partial η2 = 0.153, Cohen’s f = 0.42] after adjusting
for relevant covariates. Pairwise comparisons with Bonferroni
adjustment revealed that chronic smokers had significantly
higher “risk taking” scores (M = 0.64, SE = 0.04) compared
to non-smokers (M = 0.47, SE = 0.04) with a mean difference
of 0.172 (95% CI, 0.03–0.30) p < 0.01. Similarly, chronic
smokers had significantly higher “overall proportion bet” scores
(M = 0.59, SE = 0.03) compared to non-smokers (M = 0.42,
SE = 0.04) with a mean difference of 0.173 (95% CI, 0.04–
0.30) p < 0.01. No statistically significant difference was found
between chronic smokers and non-smokers in relation to “risk
adjustment” scores [F(1,44) = 0.22, p = 0.63, partial η
2
=
0.00]. Finally, no statistically significant difference was identified
between chronic smokers and non-smokers in relation to “quality
of decision making” scores as assessed by a Kruskall Wallis H test
[H(1) = 1.63, p= 0.20].
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TABLE 1 | Sociodemographic characteristics, smoking characteristics, and cognitive impulsivity scores of study participants.
Session 1 Session 2
Chronic tobacco
smokers




n 28 24 23 19
Age in yrs (SD) 28.1 (8.3) 28.5 (9.5) p = 0.96 28.5 (8.3) 29.7 (9.8) p = 0.66









Level of education (SD) 3.5 (0.7) 4.2 (0.6) NS > CS =
p < 0.01
3.4 (0.8) 4.2 (0.7) NS > CS =
p < 0.01
Pre-morbid IQ (SD) 102.8 (3.6) 107.5 (4.1) NS > CS =
p < 0.001
102.4 (3.7) 107.9 (4.3) NS > CS =
p < 0.001
SIMD (SD) 2.0 (1.5) 2.6 (1.4) p = 0.12 1.7 (1.3) 2.4 (1.5) p = 0.13
Tobacco smoking characteristics
Cigarettes smoked per day 15.0 (4.5) N/A N/A 15.5 (4.2) N/A N/A
FTND 5.0 (1.5) N/A N/A 5.1 (1.5) N/A N/A
Pack years 10.4 (8.1) N/A N/A 11.2 (8.3) N/A N/A
Age at regular smoking onset in
yrs*
16.1 (3.4) N/A N/A 16.0 (3.7) N/A N/A




Units of alcohol consumed x day
(SD)
0.6 (1.0) 0.2 (0.5) p = 0.16 0.5 (0.8) 0.2 (0.3) p = 0.11




29.50 (39.22) 434.45 (922.79) NS > CS p
= < 0.01
29.58 (38.16) 517.78 (102.69) NS > CS =
p < 0.01
CGT risk taking 0.64 (0.17) 0.47(0.18) CS > NS =
p < 0.01
0.64 (0.15) 0.47 (0.19) CS > NS =
p < 0.01
CGT overall proportion bet 0.60 (0.17) 0.43 (0.17) CS > NS =
p< 0 .01
0.60 (0.15) 0.42 (0.18) CS > NS =
p < 0.01
CGT risk adjustment 1.30 (1.11) 1.79 (1.30) p = 0.63 1.46 (1.19) 1.70 (1.37) p = 0.72
CGT quality of decision making 0.94 (0.85) 0.93 (0.10) p = 0.20 0.90 (0.13) 0.92 (0.11) p = 0.23
A mean of 2.8 days separated session 1 from session 2. Data are presented in Means and Standard Deviations (SD) or in percentages (%). Sig1 = significance at p < 0.05 two
tailed. Education level scores (1 = Left formal education before age 16, 2 = Left formal education at age 16, 3 = Left formal education at age 18, 4 = Undergraduate degree, 5 =
Master’s degree/Post-Graduate Diploma, 6 = PhD). %, percentage; SIMD, Scottish index of Multiple Deprivation (1 = most deprived area to 5 = least deprived area); n, number of
participants; NS, non-smokers; CS, chronic tobacco smokers; CO, Carbon Monoxide. Yrs, years; SD, Standard Deviation; FTND, Fagerström Test for Nicotine Dependence (0–2 = very
low dependence, 2–4 = low dependence, 5 = medium dependence, 6 or more = high dependence). ADT-5, 5 trial adjusting delay discounting task; ED50, Effective delay 50; CGT,
Cambridge Gambling task.
*Age at regular smoking onset was defined as the age at which individuals started smoking 5 or more cigarettes daily.
**ADT-5 scores (ED50 values) were log10 transformed for ANCOVA analyses.
post-hoc power calculations with a sample size of 52
participants and α = 0.05 revealed a power (1-β probability) of
0.94 for choice impulsivity (ADT-5) scores, a power of 0.84 for
“overall proportion bet” scores (CGT), and a power of 0.78 for
“risk taking” scores (CGT).
Considering the dropout of 10 participants (5 smokers and
5 non-smokers) prior to the MRI session, sensitivity analyses
(ANCOVAs) were conducted to ascertain choice impulsivity
(ADT-5) and risky decision making (CGT) differences between
the remaining smokers (n = 23) and non-smokers (n = 19).
Results still revealed a significant difference (p < 0.01) between
smokers and non-smokers in relation to ED50 values, “risk
taking,” and “overall proportion bet” scores with effect sizes
(Cohen’s f ) of 0.57, 0.40, and 0.42 respectively.
Neuroimaging
Voxel based morphometry (VBM) results revealed GM volume
reductions in chronic tobacco smokers compared to non-
smokers in several cortical and striatal brain regions across the
whole brain, predominantly in the left hemisphere. Structures
presenting GM volume reductions, cluster sizes, Brodmann’s
areas (BA), and corresponding Montreal Neurological Institute
(MNI) coordinates are reported in Supplementary Table 3.
Regions of Interest displayed GM volume reductions in frontal
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FIGURE 1 | Voxel-wise regression results depicting positive relationships between ED50 values and GM volume in the left VLPFC, left ACC, and bilateral caudate
while controlling for total intracranial volume (TIV), age, and biological sex. The cluster-forming threshold consisted in p < 0.05 with a minimum of 100 contiguous
voxels per cluster. The figure shows the location of the left VLPFC (A), left caudate (C), and right caudate (E) voxel clusters in coronal slices. The location of the left
ACC voxel cluster (G) is depicted in an axial slice. For visualization purposes, the scatterplot of adjusted response data (B) shows the significant (p < 0.005) reduction
in GM volume as a function of ED50 values in the left VLPFC (cluster size: 1624 voxels). The scatterplot of adjusted response data (D) shows the significant (p <
0.005) reduction in GM volume as a function of ED50 values in the left caudate (cluster size: 469 voxels). The scatterplot of adjusted response data (F) shows the
significant (p < 0.005) reduction in GM volume as a function of ED50 values in the right caudate (cluster size: 728 voxels). The scatterplot of adjusted response data
(H) shows the significant (p < 0.005) reduction in GM volume as a function of ED50 values in the left ACC (cluster size: 732 voxels). Plotted values consist in residuals
of mean GM volume (Y axis) and of mean ED50 values (X axis). R2: Coefficient of determination.
Frontiers in Psychiatry | www.frontiersin.org 6 August 2021 | Volume 12 | Article 708925
Conti and Baldacchino Neuroanatomical Correlates of Impulsivity in Young Smokers
FIGURE 2 | Voxel-wise regression results depicting negative relationships between risk taking scores, overall proportion bet scores, and GM volume in the left ACC
while controlling for total intracranial volume (TIV), age, and biological sex. The cluster-forming threshold consisted in p < 0.05 with a minimum of 100 contiguous
voxels per cluster. The figure shows the location of the left ACC voxel clusters in axial (A) and coronal (C) slices. For visualization purposes, the scatterplot of adjusted
response data (B) shows the significant (p < 0.005) reduction in GM volume as a function of risk-taking scores in the left ACC (cluster size: 256 voxels). The
scatterplot of adjusted response data (D) shows the significant (p < 0.005) reduction in GM volume as a function of overall proportion bet scores in the left ACC
(cluster size: 227 voxels). Plotted values consist in residuals of mean GM volume (Y axis) and of mean risk taking and overall proportion bet scores (X axis). R2:
Coefficient of determination.
cortices such as the bilateral ACC (14, 21, 29;−11, 26, 18; BA32),
left DLPFC (−21, 41, 23; BA9), left VLPFC (−26, 35,−12; BA47),
and left OFC (−5, 44,−27; BA11). Striatal graymatter reductions
in chronic smokers compared to non-smokers were present in the
left caudate (−11, 2, 12), and in the left putamen (−21,−9, 6).
Relationship Between Neuroimaging and
Non-neuroimaging Measures
A positive relationship was detected between choice impulsivity
scores (ED50 values) and GM volume in regions of interest.
These included the left VLPFC (−50, 30,−18; BA47) (p= 0.002;
T = 3.20; R2 = 0.251), left caudate (−18,−2, 30) (p= 0.002; T =
3.21; R2 = 0.336), right caudate (18, 0, 30) (p = 0.002; T = 3.37,
R2 = 0.281), and left ACC (−17, 42, 5, BA32) (p < 0.0001; T =
4.57, R2 = 0.365) of chronic tobacco smokers. These associations
are depicted in Figure 1. Furthermore, a negative relationship
was detected between “risk taking” (p =0.001; T = 3.62; R2 =
0.409) and “overall proportion bet” (p = 0.002; T = 3.34; R2
= 0.371) scores of the CGT and GM volume in the left ACC
(−9, 33, 21; BA 32) of chronic tobacco smokers (see Figure 2).
Supplementary Tables 4, 5 depict the associations between risky
decision making, impulsive choices and GM volume in brain
regions of no interest (not related to the a priori hypotheses listed
in the section Introduction).
Negative and positive relationships were also detected
between GM volume in regions of interest and smoking
variables. These are depicted in Table 2. Regression plots
showing the directions of these associations are illustrated in
Supplementary Figure 2. Supplementary Table 6 illustrates the
associations between tobacco smoking variables and GM volume
in brain regions of no interest.
DISCUSSION
Summary of Findings
a) Chronic tobacco smokers displayed GM volume reductions
in various brain areas (predominantly in the left hemisphere
of the brain), including striatal and cortical a priori regions
of interest located in the prefrontal cortex, supporting
hypothesis 1.
b) Chronic tobacco smokers displayed heightened impulsive
choices and a riskier decision-making process in comparison
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TABLE 2 | Voxel-wise regression results depicting significant associations between GM volume in regions of interest and smoking variables while controlling for TIV, age,
and biological sex.




P-values Cluster size (k) R2 Region of interest
Age at regular smoking onset L 9 −29, 32, 32 3.36 p < 0.005 125 0.341 DLPFC
L 47 −39, 30, −2 2.86 p < 0.005 116 0.274 VLPFC
Pack years L 8 −14, 33, 39 4.81 p < 0.0001 474 0.211 DLPFC
L N/A −24, 3, 5 4.10 p < 0.0001 174 0.183 Putamen
L 10 −17, 54, 0 3.59 p < 0.005 105 0.154 ACC
L N/A −9, 11, 6 3.56 p < 0.005 132 0.154 Caudate
L 46 −41,21, 23 3.40 p < 0.005 335 0.146 DLPFC
Cigarettes smoked per day L N/A −26, −2, 5 3.71 p < 0.005 195 0.284 Putamen
FTND L N/A −15, −23, 5 3.25 p < 0.005 197 0.251 Thalamus
L 47 −50, 42, −2 3.04 p < 0.005 125 0.226 VLPFC
The Cluster forming threshold consisted in p < 0.01 (uncorrected) with a minimum of 100 contiguous voxels (k) per cluster. MNI, Montreal Neurological Institute; VLPFC, VentroLateral
PreFrontal Cortex; DLPFC, Dorsolateral PreFrontal cortex; ACC, anterior cingulate cortex; T, t-statistics; BA, Brodmann’s area.
to non-smoker controls as assessed by the ADT-5 and CGT
tasks, supporting hypothesis 2.
c) GM volume reductions in cortical and striatal a priori regions
of interest were correlated to impulsive choices (VLPFC,
caudate, ACC) and risky decision making (ACC) in chronic
tobacco smokers, supporting hypothesis 3.
Interpretation
These results are in line with recent findings demonstrating a
strong association between chronic tobacco smoking, impulsive
choices, and risky decision making (6, 7). That is, chronic
tobacco smokers have a greater difficulty in delaying immediate
gratification and display a riskier decision-making process in
comparison to non- smokers. The current study adds up
to the body of knowledge by revealing a cross- sectional
relationship between impulsive choices, risky decision making,
and GM volume reductions in chronic tobacco smokers not
affected by psychiatric comorbidity, poly substance dependence
(e.g., alcoholism), and/or chronic medical conditions (e.g.,
HIV). These deficits were detected in a relatively young
sample of cigarettes smokers with a mean age of 28 years
old. Thus, it is unlikely that participants were affected by
neurocognitive impairments that are a consequence of the aging
process (34).
Under a neuroanatomical point of view, the above findings
are in line with previous studies revealing GM volume reductions
in striatal and cortical structures located in the prefrontal cortex
of chronic tobacco smokers (17–19). In accordance with these
studies, the current research revealed a negative relationship
between tobacco exposure variables and reduced GM volume
in prefrontal and striatal brain regions. Specifically, longer pack
years were associated to reduced GM volume in the left DLPFC,
left ACC, left caudate, and left putamen. Severity of nicotine
dependence (FTND score) was also associated with GM volume
reductions in the left thalamus, an area strictly related to the
development and maintenance of substance dependence for
its dopaminergic projections (35). The current study provides
support to the findings of Durazzo et al. (21) by revealing a
correlation between GM volume reductions in the left ACC
and risky decision making in chronic smokers. Furthermore, the
current study revealed a positive association between GM volume
reductions in the left ACC and the inability to delay gratification
displayed by chronic smokers (ED50 values). Indeed, the ACC
has been proposed to play a crucial role in the maintenance
of addictive behaviors due to its connections with the limbic
system and prefrontal cortex, therefore mediating maladaptive
emotional and reward-based decisions (36). The association
between GM volume reductions in the VLPFC and heightened
impulsive choices displayed by chronic smokers extends previous
work by endorsing disruptions in brain’s executive system as a
core feature of nicotine dependent individuals (36).
Notably, impairments in cognitive impulsivity for chronic
smokers enrolled in the current study correlated to GM volume
reductions localized predominantly in the left hemisphere
of the brain. Despite GM deficits being reported frequently
in left fronto-cortical and striatal brain regions in chronic
tobacco smokers (19, 37, 38), no association between cognitive
impairments and lateralization of structural brain deficits in
chronic smokers was ever investigated. However, an fMRI study
conducted by Clewett et al. (39) revealed greater functional
coupling between the left fronto- parietal network and the
left insular cortex in chronic tobacco smokers compared
to non-smokers while performing a computerized Delay
Discounting task (with hypothetical monetary rewards) (39).
Greater functional connectivity between these areas was also
associated to steeper discounting rates (39). Furthermore, a
systematic review conducted by Gordon (40) showed greater
peak activation in fronto-cortical brain areas located in the left
hemisphere of tobacco deprived smokers while responding to
cue-reactivity (craving) stimuli during fMRI investigations (40).
Therefore, consistently with the CNDS model, the simultaneous
hyperactivation of the left reward system to cigarettes cues,
and the inability to delay gratification caused by GM volume
reductions in the left VLPFC and left ACC, may induce cigarettes
smokers to crave for, and to want immediately the drug of abuse
(i.e. cigarettes) despite the known health risks associated to its
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usage. Indeed, impulsivity has been linked to tobacco craving and
smoking relapses by the literature (41).
Even though the cross-sectional nature of the current research
does not allow to directly imply causation, the above findings
may be explained by neuroscience- based paradigms. According
to the “tobacco Induced neurotoxicity theory of adolescent
cognitive development” (TINACD) (42), exposure to tobacco
during adolescence (a developmental period characterized by
intense neurostructural and neurochemical maturation) may
cause long-lasting deficits in frontal brain areas modulating
cognitive functions mostly related to top- down inhibitory
control and decision making (42). For this reason, adult smokers
who initiated tobacco use during adolescence may have more
difficulties quitting smoking, and relapse more frequently, in
comparison to individuals who started smoking at a later
developmental stage (42). This theory has been availed by
animal models revealing unique, and long- lasting, cellular
alterations and structural changes in fronto-cortical and striatal
brain regions of rats exposed to nicotine during adolescence
(43, 44). In support to the TINACD, the current study revealed
a positive correlation between younger age at regular smoking
onset (mean = 16 years) and GM volume reductions in the left
VLPFC (BA 47), (Table 2). As described previously, GM volume
reductions in the left VLPFC (BA 47) were also associated to
heightened impulsive choices in the current sample (Figure 1).
An alternative interpretation to the above findings consists
in the presence neurocognitive endophenotypes in substance
dependent populations (45). In fact, studies have shown
abnormal brain structures in fronto-cortical and striatal brain
regions, and related cognitive impulsivity impairments, in
substance dependent individuals and their drug- naïve biological
siblings (46, 47). However, because of the lack of longitudinal
studies, the causal relationship between chronic tobacco smoking
and neurocognitive impairments remains unclear (48).
Clinical Relevance
Considering that impaired cognitive impulsivity may be
determinant in fostering tobacco smoking during different stages
of the drug addiction cycle (initiation, maintenance, relapse)
(8, 11), results from this study may inform smoking cessation
treatments, and neuroscience-based interventions for tobacco
use and dependence. Specifically, the identification of GM
volume reductions in brain areas related to different aspects of
cognitive impulsivity (ACC to risky decision making, VLPFC,
ACC, and caudate to impulsive choices), and the proposed
left lateralization of these neurocognitive impairments, may
aid the improvement of technology-based neuromodulation
interventions such as transcranial direct current stimulation
(tDCS) and transcranial magnetic stimulation (rTMS). In fact,
such interventions have provided limited and contrasting results
for the treatment of nicotine dependence (49).
Moreover, the inability to delay gratification, commonly
featured by chronic smokers (7), should be considered a
primary target for cognitive rehabilitation therapies (CRTs) (50).
Studies have also proposed Episodic Future Thinking (ETF)
interventions as effective means to decrease delay discounting
rates, cigarette self- administration, and cigarette demand (51).
Strengths and Limitations
The current study should be considered in light of several
limitations. First, the size of the sample enrolled in the current
study was relatively small, therefore limiting the power of
risky decision making (CGT) results. However, post-hoc power
calculations for choice impulsivity (ADT-5) results revealed
an achieved power of 0.94 with a very large effect size of
0.5. Additionally, participants were all recruited from the
same deprived metropolitan area, thus generalizability may be
limited to Scottish chronic smokers from a low socio-economic
background (SES). Studies have proposed a relationship between
low SES, brain development deficits, and cognitive impairments
(52). Although, chronic tobacco smoking has been recently
found to mediate these associations (53). Another limitation
consists in the utilization of self- reported questionnaires to
assess alcohol consumption patterns and smoking characteristics
of participants (pack years, cigarettes smoked per day, age
at regular smoking onset) as participants may have provided
inaccurate information. Nonetheless, a rigorous screening
procedure involving different objective measurements to assess
smoking status (exhaled CO, salivary cotinine) and to exclude
the presence of other substances in participants’ system (urine
analysis) was employed. The recruitment of a younger chronic
smoker sample not affected by polysubstance dependence and
characterized by minimal alcohol and cannabis use, with the
utilization of stringent exclusion and inclusion criteria, may be
considered strengths of the current study.
Conclusion
The current study revealed an association between left fronto-
cortical and striatal GM volume reductions and impaired
cognitive impulsivity in chronic tobacco smokers. GM volume
reductions in the left VLPFC correlated to heightened impulsive
choices and to younger age at regular smoking onset. Considering
that the cross-sectional nature of the current research limits
inferences of causal effects, longitudinal studies would be
required to elucidate if these neurocognitive impairments are
representations of pre-morbid endophenotypes or are caused by
tobacco exposure on the developing adolescent brain.
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